Ciphergen to Webcast Presentation at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference, Monaco

FREMONT, Calif., May 8  /PRNewswire-FirstCall/ -- Ciphergen (NASDAQ:CIPH) announced today that it will webcast its presentation at the Rodman & Renshaw's Global Healthcare Conference in Monaco.  Gail Page, President & CEO, will provide a company overview at 5:10 a.m. EDT on Monday, May 14, 2006.

A webcast of the presentation will be available live and by replay.  To access both the live and archived webcast, please go to http://www.ciphergen.com/ and click on the "Investors" link.  The archived replay will be available for 24 hours after the live presentation and will be accessible for 30 days.

About Ciphergen

Ciphergen Biosystems, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Ciphergen, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology, cardiology and women's health with an initial focus in ovarian cancer. Based in Fremont, California, more information about Ciphergen can be found on the Web at http://www.ciphergen.com/. 

DATASOURCE: Ciphergen Biosystems, Inc.



CONTACT:  Sue Carruthers, Investor Relations of Ciphergen Biosystems,

Inc., [phone]



Web site:  http://www.ciphergen.com/

Copyright